Role of nitric oxide in obesity-induced beta cell disease - PubMed (original) (raw)

Role of nitric oxide in obesity-induced beta cell disease

M Shimabukuro et al. J Clin Invest. 1997.

Abstract

Here we report that free fatty acid-induced suppression of insulin output in prediabetic Zucker diabetic fatty (ZDF) rats is mediated by NO. When normal islets were cultured in 2 mM FFA, NO production and basal insulin secretion increased slightly. In cultured prediabetic ZDF islets, FFA induced a fourfold greater rise in NO, upregulated mRNA of inducible nitric oxide synthase (iNOS), and reduced insulin output; both nicotinamide and aminoguanidine, which lower NO, prevented the FFA-mediated increase in iNOS mRNA, reduced NO, and minimized the loss of insulin secretion. In vivo nicotinamide or aminoguanidine treatment of prediabetic ZDF rats prevented the iNOS expression in islets and decreased beta cell dysfunction while blocking beta cell destruction and hyperglycemia. We conclude that NO-lowering agents prevent adipogenic diabetes in obese rats.

PubMed Disclaimer

References

1. 1. Methods Enzymol. 1975;39:364-72 - PubMed
2. 1. Proc Soc Exp Biol Med. 1996 Jan;211(1):24-32 - PubMed
3. 1. J Clin Invest. 1983 Nov;72(5):1737-47 - PubMed
4. 1. Diabetes. 1988 Jun;37(6):667-87 - PubMed
5. 1. Endocrinology. 1990 Oct;127(4):1580-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • American Society for Clinical Investigation
  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information